Longevity News

As Spinal Muscular Atrophy (SMA) Awareness Month Begins, Cure SMA Spotlights Progress and Persistent Gaps in SMA Care

Source: PR Newswire • Published: 07 Aug 2026, 16:14

As Spinal Muscular Atrophy (SMA) Awareness Month Begins, Cure SMA Spotlights Progress and Persistent Gaps in SMA Care

SMA Awareness Month coverage highlighting an annual nonprofit report on diagnosis, treatment access, and ongoing care gaps for the SMA community.

Key Takeaways
  • Cure SMA estimates it has connected with nearly 70% of the current U.S
  • Report has been used to inform the FDA on unmet needs
  • Median age at SMA diagnosis has fallen to just 7 days
Read Original Source

Continue exploring

Related longevity signals

Swiss BiotechNovaGo Therapeutics: USD 30 million to advance spinal cord injury studyA biotech financing update that previews a company’s planned randomized clinical study testing an anti-Nogo-A therapy for acute spinal cord injury, useful for readers tracking emerging regenerative treatments.Nature - BiotechnologySHH-functionalized fibrin scaffold improves spinal cord repair in rats and modulates primary neural stem cell behavior in vitroCovers development of a polydopamine-modified fibrin scaffold that sustains sonic hedgehog delivery to support spinal cord repair and influence neural stem cells in vitro.Frontiers - HealthRegional anesthesia after spinal cord injury attenuates behavioral loss, hemorrhage, and cell deathReports animal experiments testing whether early regional spinal anesthesia reduces hemorrhage, cell death, and behavioral loss after acute spinal cord injury.Nature - Main‘Robot Olympics’ reveal humanoids’ rapid progress — and flawsHumanoid-robot competition coverage that previews athletic feats and practical-task challenges, inviting readers curious about embodied AI’s real-world limits.